Page 22 - 中国全科医学2022-20
P. 22

http://www.chinagp.net   E-mail:zgqkyx@chinagp.net.cn  ·2451·


           4.Henan Academy of Chinese Medicine,Zhengzhou 450000,China
           *
           Corresponding author:FU Yu,Associate chief TCM physician;E-mail:kybfuyu@126.com
               【Abstract】 Background Early treatment is crucial to the delay of the progression of type 2 diabetes mellitus with
           stable angina pectoris (T2DM-SAP),which has poor prognosis,such as high rates of disability and mortality. As traditional
           Chinese medicine(TCM) has unique advantages in preventing diseases,developing a model with TCM and western medicine
           factors associated with major adverse cardiovascular and cerebrovascular events (MACCEs) incorporated may be a reliable tool
           that could be used to predict the risk of MACCEs in patients with T2DM-SAP. Objective To develop and assess the applicability
           of a risk prediction model for MACCEs in T2DM-SAP patients using identified risk factors associated with MACCEs in this group.
           Methods Participants were 674 inpatients with T2DM-SAP who received diagnostic and treatment services from The First
           Affiliated Hospital of Henan University of CM from 2012 to 2019. Through the hospital information system,electronic medical
           records and follow-up data of these patients were collected,including demographics,clinical characteristics,laboratory
           parameters,TCM symptoms and syndrome differentiation,and outcome(prevalence of MACCEs). Patients were classified
           into a MACCEs group(n=190) and a non-MACCEs group(n=484) by prevalence of MACCEs. Independent risk factors
           for MACCEs in T2DM with SAP were identified using univariate and multivariate Logistic regression,and used to develop a
           nomogram-based predictive model. Then the model was internally validated using the bootstrap approach,and its predictive value
           was estimated using ROC analysis,C-index,calibration plot,Hosmer-Lemeshow test and decision curve analysis. Results
           Based on the multivariate Logistic regression analysis,the factors associated with MACCEs in T2DM-SAP patients (P<0.05)
           included age〔OR=1.033,95%CI(1.014,1.052)〕,cerebrovascular disease history〔OR=3.799,95%CI(2.529,
           5.750)〕,serum creatinine〔OR=1.005,95%CI(1.002,1.008)〕,dark purple tongue〔OR=2.756,95%CI(1.285,
           5.935)〕,decreased tongue coating〔OR=2.083,95%CI(1.025,4.166)〕,thready pulse〔OR=5.822,95%CI(1.867,
           20.359)〕,and obstruction of collateral channels caused by wind-phlegm〔OR=2.525,95%CI(1.466,4.387)〕. The
           predictive model constructed using the above-mentioned factors showed moderate predictive power{C-index=0.769〔95%CI
           (0.729,0.809)〕,sensitivity=69.47%,specificity=75.00%},indicating a good degree of distinction. The calibration plot
           showed the average absolute error between the predictive and actual adverse outcome risks was 0.011,with a C-index of 0.761
                                                                         2
           after fitting bias correction. The Hosmer-Lemeshow test showed a good calibration(χ =6.004,P=0.647). The decision curve
           analysis displayed a threshold probability of >30%,indicating that the model may be clinically beneficial. Conclusion The risk
           predictive model for MACCEs in T2DM-SAP patients was developed using the associated factors(including age,cerebrovascular
           disease history,serum creatinine,dark purple tongue,decreased tongue coating,thready pulse,and obstruction of collateral
           channels caused by wind-phlegm) identified by us,which has been proven to have good discrimination,calibration,and
           clinical effectiveness,and could be used as a tool for assessing the risk of MACCEs in patients with T2DM-SAP.
               【Key words】 Diabetes mellitus;Stable angina pectoris;Cardiovascular and cerebrovascular events;Clinical
           predictive model;Traditional Chinese Medical


               2 型糖尿病(type 2 diabetes mellitus,T2DM)合并
                                                                行业贡献:
           稳定型心绞痛(stable angina pectoris,SAP)患者是发
                                                                    针对 2 型糖尿病合并稳定型心绞痛(T2DM-SAP)
           生主要不良心脑血管事件(major adverse cardiovascular             患者进行中西医结合治疗是预防主要不良心脑血管事
           and cerebrovascular events,MACCE)的高危人群     [1] ,
                                                                件(MACCE)发生的关键环节,但其 MACCE 发生风
           现代医学主要通过控制其危险因素来降低 MACCE 发生                          险的把握只停留于主观定性分析而无定量的精准化风
           率,但在有效减少 MACCE 方面仍面临严峻挑战                  [2-3] 。
                                                                险预测。而融合中医元素的临床预测模型的构建,不
           基于传统医学的“治未病”理念,中医药防治 T2DM-                           仅体现了中医个体化辨证论治的优势,也为 T2DM-
           SAP 方面具有独特的临床优势           [4-5] 。但“治未病”理念
                                                                SAP 患者提供了基于循证证据的数字化风险评估,实
           对 T2DM-SAP 患者的预后评估具有主观性,风险预测
                                                                现临床精准医疗,做到早评估、早发现、早防治,为
           不明确,临床防治工作证据不足。而融合中医元素的临
                                                                临床中西医结合防治 T2DM-SAP 提供科学依据。
           床预测模型的构建不仅体现了个体化辨证论治的优势,
           同时给予数字化精准的风险预测,将辨证论治的经验转                            第一附属医院诊治的 965 例 T2DM-SAP 的住院患者作
           为循证医学的证据,为临床中西医结合防治 T2DM-SAP                        为研究对象。诊断标准参照1999年世界卫生组织(WHO)
           患者发生 MACCE 提供可靠依据。                                  制定的糖尿病诊断标准          [6] 以及 2007 年中华医学会心血
           1 资料与方法                                             管病学分会制定的《慢性稳定性心绞痛诊断与治疗指
           1.1 研究对象 选取 2012—2019 年在河南中医药大学                     南》  [7] 。纳入标准:(1)符合诊断标准;(2)年龄、
   17   18   19   20   21   22   23   24   25   26   27